These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4230052)

  • 1. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G; Gibelli A; Giarola P
    Clin Ter; 1966 Jul; 38(1):27-38. PubMed ID: 4230052
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic activity and reduction of platelet adhesiveness following prolonged administration of ethyl-chlorophenoxy-isobutyrate (Atromid-S).
    Gibelli A; Frandoli G; Giarola P; De Nicola P
    Hemostase; 1966 Oct; 6(4):285-6. PubMed ID: 5986050
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of chlorophenoxy-isobutyric ester on platelet adhesiveness and aggregation in the patients with arteriosclerosis and diabetes mellitus].
    Yasunaga K
    Naika Hokan; 1969 Oct; 16(10):393-403. PubMed ID: 5391800
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use].
    Guglielmi G; Barlattani M; Garbagnati N; Iaschi P; Ciavarelli F
    Clin Ter; 1969 Sep; 50(6):527-36. PubMed ID: 5406050
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of clofibrate on serum lipids in atherosclerosis].
    Gietz E
    Med Klin; 1967 Mar; 62(9):336-8 passim. PubMed ID: 5593571
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-benzal-butyric acid, a new anti-adhesive drug.
    Mannucci PM; Maggi CA; Gioventu M; Marchi E; Terruzzi AB
    Acta Univ Carol Med Monogr; 1972; 53():409-12. PubMed ID: 4670746
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of Clofibrate on blood coagulation].
    Barth P; Kommerell B
    Med Klin; 1966 Sep; 61(37):1466-8. PubMed ID: 4867653
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aggregation and adhesiveness of blood platelets in the physiopathology and prevention of thrombophilic states. Prospects and results of experimental and clinical research].
    De Nicola P; Gibelli A; Frandoli G; Giarola P; Turazza G
    G Gerontol; 1966 Oct; 14(10):941-51. PubMed ID: 5993790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Regelan (Atromid-S) on serum lipids and platelet aggregation in occlusive arterial disease].
    Fischer M; Irsigler K
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):248-51. PubMed ID: 4880993
    [No Abstract]   [Full Text] [Related]  

  • 13. [Further data on the use of a preparation with antisclerotic action in geriatrics].
    Solaro F; Zinnari A; Dinale M
    G Gerontol; 1970 Mar; 18(3):177-84. PubMed ID: 5473220
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of ethyl-chlorphenoxy-isobutyrate on serum lipid values in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diezendy S; Erdélyi G
    Orv Hetil; 1966 May; 107(22):1020-2. PubMed ID: 5935787
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood fibrinolytic potential during acute myocardial infarction].
    Courbier R; Jausseran JM; Forlot P; Torresani J; Henry E; Jouve A
    Presse Med (1893); 1971 Oct; 79(41):1789-92. PubMed ID: 4256155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T
    Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.